IL142118A0 - Method and composition for treatment of skeletal dysplasias - Google Patents
Method and composition for treatment of skeletal dysplasiasInfo
- Publication number
- IL142118A0 IL142118A0 IL14211801A IL14211801A IL142118A0 IL 142118 A0 IL142118 A0 IL 142118A0 IL 14211801 A IL14211801 A IL 14211801A IL 14211801 A IL14211801 A IL 14211801A IL 142118 A0 IL142118 A0 IL 142118A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- composition
- skeletal dysplasias
- dysplasias
- skeletal
- Prior art date
Links
- 206010072610 Skeletal dysplasia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14211801A IL142118A0 (en) | 2001-03-20 | 2001-03-20 | Method and composition for treatment of skeletal dysplasias |
PCT/IL2002/000229 WO2002074234A2 (fr) | 2001-03-20 | 2002-03-20 | Methode et composition permettant le traitement de dysplasies du squelette |
AU2002241228A AU2002241228A1 (en) | 2001-03-20 | 2002-03-20 | Method and composition for treatment of skeletal dysplasias |
CA2441815A CA2441815C (fr) | 2001-03-20 | 2002-03-20 | Methode et composition permettant le traitement de dysplasies du squelette |
IL157922A IL157922A (en) | 2001-03-20 | 2003-09-14 | Composition comprising natriuretic peptide variant for treatment of skeletal dysplasias |
US10/664,605 US7276481B2 (en) | 2001-03-20 | 2003-09-15 | Method and composition for treatment of skeletal dysplasias |
US11/840,631 US20080194682A1 (en) | 2001-03-20 | 2007-08-17 | Method and composition for treatment of skeletal dysplasias |
US12/612,645 US20100055150A1 (en) | 2001-03-20 | 2009-11-04 | Method and composition for treatment of skeletal dysplasias |
US13/006,129 US20120328699A1 (en) | 2001-03-20 | 2011-01-13 | Method and composition for treatment of skeletal dysplasias |
IL213845A IL213845A0 (en) | 2001-03-20 | 2011-06-29 | Method and composition for treatment of skeletal dysplasias |
US14/255,773 US20140271868A1 (en) | 2001-03-20 | 2014-04-17 | Treatment of achondroplasia with encapsulated cnp-secreting cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27693901P | 2001-03-20 | 2001-03-20 | |
IL14211801A IL142118A0 (en) | 2001-03-20 | 2001-03-20 | Method and composition for treatment of skeletal dysplasias |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142118A0 true IL142118A0 (en) | 2002-03-10 |
Family
ID=26324017
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14211801A IL142118A0 (en) | 2001-03-20 | 2001-03-20 | Method and composition for treatment of skeletal dysplasias |
IL157922A IL157922A (en) | 2001-03-20 | 2003-09-14 | Composition comprising natriuretic peptide variant for treatment of skeletal dysplasias |
IL213845A IL213845A0 (en) | 2001-03-20 | 2011-06-29 | Method and composition for treatment of skeletal dysplasias |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL157922A IL157922A (en) | 2001-03-20 | 2003-09-14 | Composition comprising natriuretic peptide variant for treatment of skeletal dysplasias |
IL213845A IL213845A0 (en) | 2001-03-20 | 2011-06-29 | Method and composition for treatment of skeletal dysplasias |
Country Status (5)
Country | Link |
---|---|
US (5) | US7276481B2 (fr) |
AU (1) | AU2002241228A1 (fr) |
CA (1) | CA2441815C (fr) |
IL (3) | IL142118A0 (fr) |
WO (1) | WO2002074234A2 (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0203172B8 (pt) | 2001-09-28 | 2021-05-25 | Nakao Kazuwa | composição farmacêutica para acondroplasia |
CA2430889A1 (fr) * | 2002-06-19 | 2003-12-19 | Bayer Corporation | Stabilisation du peptide natriuretique cerebral (bnp) dans des echantillons de sang, et methodes et composes connexes |
US20080214437A1 (en) * | 2002-09-06 | 2008-09-04 | Mohapatra Shyam S | Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
US7655772B2 (en) * | 2002-09-06 | 2010-02-02 | University Of South Florida | Materials and methods for treatment of allergic diseases |
US20060110359A1 (en) * | 2002-09-06 | 2006-05-25 | Juan Sanchez-Ramos | Cellular delivery of natriuretic peptides |
WO2004062555A2 (fr) * | 2003-01-13 | 2004-07-29 | Gudrun Rappold-Hoerbrand | Utilisation de peptides natriuretiques dans le traitement de troubles affectant la taille associes au gene shox |
GB2403533A (en) | 2003-06-30 | 2005-01-05 | Orion Corp | Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof |
ES2403357T3 (es) | 2003-12-11 | 2013-05-17 | Isto Technologies Inc. | Sistema de cartílago particulado |
CA2559853A1 (fr) * | 2004-02-17 | 2005-10-13 | University Of South Florida | Materiaux et methodes permettant de traiter des troubles inflammatoires et lies a la proliferation cellulaire |
CN1960758B (zh) | 2004-03-31 | 2014-10-22 | 中外制药株式会社 | 关节炎的治疗剂或预防剂 |
EP3446711A1 (fr) | 2004-03-31 | 2019-02-27 | Kazuwa Nakao | Composition pour augmenter la hauteur du corps |
DK3404102T3 (da) | 2004-04-21 | 2021-09-06 | Alexion Pharma Inc | Knogletilførselskonjugater og fremgangsmåde til anvendelse heraf til målretning af proteiner mod knogle |
ATE496060T1 (de) | 2004-07-15 | 2011-02-15 | Univ Queensland | Proteinartige verbindungen und anwendungen davon |
JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
US7803901B2 (en) * | 2005-09-16 | 2010-09-28 | Mayo Foundation For Medical Education And Research | Polypeptides with natriuresis activity |
WO2007127487A2 (fr) * | 2006-04-28 | 2007-11-08 | University Of South Florida | Matières et procédés destinés à réduire une inflammation par inhibition du récepteur du peptide natriurétique auriculaire |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
CA2684040C (fr) | 2007-04-12 | 2016-12-06 | Isto Technologies, Inc. | Procede de formation d'un implant a l'aide d'un moule imitant la forme du site tissulaire defectueux et implant forme a partir de celui-ci |
KR20100057063A (ko) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드의 용도 |
JP2011504506A (ja) * | 2007-11-21 | 2011-02-10 | バイオマリン ファーマシューティカル インコーポレイテッド | C型ナトリウム利尿ペプチドの変異体 |
EP3175863B1 (fr) * | 2009-05-20 | 2021-12-01 | BioMarin Pharmaceutical Inc. | Variantes du peptide natriurétique de type c |
US20120108514A1 (en) | 2009-07-09 | 2012-05-03 | University Of Iowa Research Foundation | Long acting atrial natriuretic peptide (la-anp) and methods for use thereof |
KR101226165B1 (ko) | 2009-07-23 | 2013-01-24 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
BR112012006579A2 (pt) * | 2009-09-25 | 2016-11-22 | Alcon Res Ltd | agonistas de npr-b. |
AU2015255299B2 (en) * | 2009-09-25 | 2018-01-25 | Takeda Pharmaceutical Company Limited | Novel npr-b agonists |
TW201121995A (en) | 2009-12-18 | 2011-07-01 | Alcon Res Ltd | Novel NPR-B agonists |
WO2011153531A1 (fr) * | 2010-06-04 | 2011-12-08 | University Of South Florida | Procédé de traitement de dysplasies squelettiques mettant en œuvre un vasodilatateur |
US9266939B2 (en) | 2010-12-27 | 2016-02-23 | Alexion Pharmaceuticals, Inc. | Compositions comprising natriuretic peptides and methods of use thereof |
EP3269382A1 (fr) | 2011-01-21 | 2018-01-17 | Igisu Co., Ltd. | Agent thérapeutique pour l'alopécie |
EP2678002A2 (fr) | 2011-02-25 | 2014-01-01 | Medtronic, Inc. | Thérapie pour néphropathie et/ou insuffisance cardiaque |
US10184942B2 (en) | 2011-03-17 | 2019-01-22 | University Of South Florida | Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer |
US9102707B2 (en) | 2011-08-30 | 2015-08-11 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides |
EP2750697A4 (fr) | 2011-09-02 | 2015-03-25 | Medtronic Inc | Compositions de peptides natriurétiques chimériques et procédés de préparation |
CA2852874A1 (fr) * | 2011-10-19 | 2013-04-25 | Alexion Pharma Holding | Compositions comprenant une phosphatase alcaline et/ou un peptide natriuretique et leurs procedes d'utilisation |
WO2013103896A1 (fr) | 2012-01-06 | 2013-07-11 | Mayo Foundation For Medical Education And Research | Traitement de maladies cardiovasculaires ou rénales |
JPWO2013161895A1 (ja) * | 2012-04-25 | 2015-12-24 | 第一三共株式会社 | 骨修復促進剤 |
US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
WO2014111744A1 (fr) | 2013-01-16 | 2014-07-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Polypeptide de récepteur 3 du facteur de croissance fibroblastique (fgr3) soluble pour l'utilisation dans la prévention ou le traitement de troubles du retard de croissance squelettique |
EP3094350B1 (fr) | 2014-01-15 | 2020-03-04 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Agents ciblant le cartilage et leur utilisation |
US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
JP6787894B2 (ja) | 2014-12-05 | 2020-11-18 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 組換えアルカリホスファターゼを用いた発作の処置 |
CA2973883A1 (fr) | 2015-01-28 | 2016-08-04 | Alexion Pharmaceuticals, Inc. | Methodes de traitement d'un sujet atteint d'une deficience en phosphatase alcaline |
WO2016194855A1 (fr) * | 2015-05-29 | 2016-12-08 | 株式会社イギス | Peptide cyclique, et médicament, préparation à usage externe et produit cosmétique contenant tous ledit peptide cyclique |
BR112018001761A2 (pt) | 2015-07-30 | 2018-09-18 | Biomarin Pharmaceutical Inc. | uso de variantes de peptídeo natriurético tipo c para tratar a displasia esquelética |
KR20180029255A (ko) * | 2015-07-31 | 2018-03-20 | 가부시키가이샤 이기스 | Cnp 고리형 펩티드 및 그 고리형 펩티드를 포함하는 의약품, 외용제 및 화장료 |
CN108350440A (zh) | 2015-08-17 | 2018-07-31 | 阿雷克森制药公司 | 碱性磷酸酯的制造 |
EP3355904A4 (fr) | 2015-09-28 | 2019-06-12 | Alexion Pharmaceuticals, Inc. | Identification de régimes posologiques efficaces pour une thérapie de l'hypophosphatasie de remplacement de l'enzyme phosphatase alcaline non spécifique à des tissus (tnsalp) |
WO2017074466A1 (fr) | 2015-10-30 | 2017-05-04 | Alexion Pharmaceuticals, Inc. | Méthodes de traitement de la craniosynostose chez un patient |
WO2017100400A2 (fr) | 2015-12-08 | 2017-06-15 | Biomarin Pharmaceutical Inc. | Utilisation de variants du peptide natriurétique de type c pour traiter l'arthrose |
US11065306B2 (en) | 2016-03-08 | 2021-07-20 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
US10898549B2 (en) | 2016-04-01 | 2021-01-26 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
MX2018011833A (es) | 2016-04-01 | 2019-02-13 | Alexion Pharma Inc | Tratamiento para la debilidad muscular con fosfatasas alcalinas. |
WO2017214130A1 (fr) | 2016-06-06 | 2017-12-14 | Alexion Pharmaceuticals, Inc. | Impact du métal sur la production des phosphatases alcalines |
MX2018016257A (es) | 2016-07-07 | 2019-11-21 | Therachon Sas | Polipéptidos del receptor 3 del factor de crecimiento de fibroblastos solubles (sfgfr3) y usos de los mismos. |
EP3500289A4 (fr) | 2016-08-18 | 2020-05-06 | Alexion Pharmaceuticals, Inc. | Procédés de traitement de la trachéobronchomalacie |
CA3057502A1 (fr) | 2017-03-31 | 2018-10-04 | Alexion Pharmaceuticals, Inc. | Methodes de traitement de l'hypophosphatasie (hpp) chez l'adulte et l'adolescent |
JP2021519590A (ja) | 2018-03-30 | 2021-08-12 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 糖タンパク質の製造 |
KR20230024353A (ko) * | 2020-06-12 | 2023-02-20 | 파마인 코포레이션 | C형 나트륨이뇨 펩타이드 및 이의 암 치료에서의 방법 |
IL309798A (en) | 2021-07-09 | 2024-02-01 | Biomarin Pharm Inc | Variants of C-type natriuretic peptide for the treatment of skeletal dysplasia in children |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
JP3026351B2 (ja) | 1990-07-13 | 2000-03-27 | 壽之 松尾 | ブタcnp遺伝子及び前駆体蛋白 |
JP2977159B2 (ja) | 1990-09-07 | 1999-11-10 | 壽之 松尾 | カエル由来新規生理活性ペプチド(カエルcnp) |
JP3026352B2 (ja) | 1990-09-11 | 2000-03-27 | 壽之 松尾 | ラットCNPcDNA及び前駆体蛋白 |
JP3026354B2 (ja) | 1990-09-27 | 2000-03-27 | 壽之 松尾 | ヒトcnp遺伝子及び前駆体蛋白 |
JP2809533B2 (ja) | 1991-01-31 | 1998-10-08 | 壽之 松尾 | Cnp類似体ペプチド |
ATE253639T1 (de) * | 1991-08-19 | 2003-11-15 | Daiichi Suntory Pharma Co Ltd | Verfahren zur herstellung von peptiden |
IL99666A (en) | 1991-10-07 | 1996-09-12 | Yeda Res & Dev | Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
US5846932A (en) | 1993-11-12 | 1998-12-08 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
US5817789A (en) | 1995-06-06 | 1998-10-06 | Transkaryotic Therapies, Inc. | Chimeric proteins for use in transport of a selected substance into cells |
DK0892789T4 (da) * | 1996-04-12 | 2010-04-06 | Warner Lambert Co | Irreversible inhibitorer af tyrosin kinaser |
US6329375B1 (en) * | 1997-08-05 | 2001-12-11 | Sugen, Inc. | Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors |
WO2000061631A1 (fr) | 1999-04-12 | 2000-10-19 | Astrazeneca Ab | Antagonistes de pentapeptides modifies du recepteur de la clairance des peptides natriuretiques auriculaires |
BRPI0203172B8 (pt) * | 2001-09-28 | 2021-05-25 | Nakao Kazuwa | composição farmacêutica para acondroplasia |
JP2003190259A (ja) * | 2001-12-28 | 2003-07-08 | Hisako Ogawara | 人工臓器用チャンバー |
US7470668B2 (en) * | 2005-08-24 | 2008-12-30 | Enobia Pharma Inc. | Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof |
-
2001
- 2001-03-20 IL IL14211801A patent/IL142118A0/xx unknown
-
2002
- 2002-03-20 WO PCT/IL2002/000229 patent/WO2002074234A2/fr active Search and Examination
- 2002-03-20 AU AU2002241228A patent/AU2002241228A1/en not_active Abandoned
- 2002-03-20 CA CA2441815A patent/CA2441815C/fr not_active Expired - Fee Related
-
2003
- 2003-09-14 IL IL157922A patent/IL157922A/en active IP Right Review Request
- 2003-09-15 US US10/664,605 patent/US7276481B2/en not_active Expired - Lifetime
-
2007
- 2007-08-17 US US11/840,631 patent/US20080194682A1/en not_active Abandoned
-
2009
- 2009-11-04 US US12/612,645 patent/US20100055150A1/en not_active Abandoned
-
2011
- 2011-01-13 US US13/006,129 patent/US20120328699A1/en not_active Abandoned
- 2011-06-29 IL IL213845A patent/IL213845A0/en unknown
-
2014
- 2014-04-17 US US14/255,773 patent/US20140271868A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140271868A1 (en) | 2014-09-18 |
WO2002074234A2 (fr) | 2002-09-26 |
CA2441815C (fr) | 2014-09-23 |
AU2002241228A1 (en) | 2002-10-03 |
US20120328699A1 (en) | 2012-12-27 |
IL157922A (en) | 2011-08-31 |
US20100055150A1 (en) | 2010-03-04 |
US20080194682A1 (en) | 2008-08-14 |
US7276481B2 (en) | 2007-10-02 |
IL213845A0 (en) | 2011-07-31 |
US20040138134A1 (en) | 2004-07-15 |
WO2002074234A3 (fr) | 2005-01-06 |
CA2441815A1 (fr) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213845A0 (en) | Method and composition for treatment of skeletal dysplasias | |
AU2002364364A8 (en) | Method of treating apoptosis and compositions thereof | |
EP1416961A4 (fr) | Composition et procede pour le traitement d'une maladie | |
GB0014969D0 (en) | Novel method of treatment | |
HK1048949A1 (en) | Method and composition for the treatment of scars | |
GB0110288D0 (en) | Composition and treatment method | |
IL158251A0 (en) | Treatment of collagen | |
EP1393708A4 (fr) | Procede de traitement des cheveux | |
EP1379242A4 (fr) | Methode de traitement de cancers et compositions appropriees | |
IL153687A0 (en) | Composition and method for enhancing elasticity of tissue | |
AU2001240046A1 (en) | Method of treating skin conditions | |
GB0119583D0 (en) | Cosmetic composition and method of treating skin | |
EP1425027A4 (fr) | Methode et composition pour le traitement de plaies et de brulures | |
HK1069829A1 (en) | Surface treatment composition and method | |
EP1389105A4 (fr) | Methode de traitement | |
GB0112216D0 (en) | Method of treatment | |
GB2399500B (en) | Composition and method for treatment of wounds | |
AU2003282593A8 (en) | Polyphenolamine composition and method of use | |
EP1423118A4 (fr) | Procede et preparation de traitement du cancer | |
GB0118892D0 (en) | Method of treatment | |
GB0008921D0 (en) | Method of treatment | |
GB0111441D0 (en) | Method and kit for the treatment of cosmetic skin conditions | |
AUPR434501A0 (en) | Composition and method of treatment | |
AU2001247546A1 (en) | Method and composition for treatment and prevention of alopecia | |
GB0116029D0 (en) | Method of treatment |